Company Filing History:
2 out of 12 
1 out of 34 Years Active: 2011-2012
Title: Kevin Meyer: Innovator in Antifungal Compounds
Introduction
Kevin Meyer is a notable inventor based in Lebanon, IN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antifungal compounds. With a total of 2 patents, his work focuses on innovative solutions for treating microbial and fungal infections.
Latest Patents
Meyer’s latest patents include novel crystalline forms of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one. These patents detail pharmaceutical compositions containing these crystalline forms, methods for their use in treating and preventing various microbial and fungal infections, and processes for obtaining these crystalline forms. Specifically, the patents describe the unique crystalline Forms I, II, III, IV, V, and VI of the compound, represented by a specific formula.
Career Highlights
Throughout his career, Kevin Meyer has worked with reputable companies in the pharmaceutical industry. Notable among these are Palau Pharma, S.A. and Stiefel Laboratories, Inc. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.
Collaborations
Meyer has collaborated with several professionals in his field, including Antonio Cánovas Paredes and Javier Bartroli Orpi. These collaborations have likely enhanced his research and development efforts in antifungal compounds.
Conclusion
Kevin Meyer stands out as an innovator in the pharmaceutical industry, particularly in the realm of antifungal treatments. His patents and career achievements reflect his commitment to advancing medical science and improving patient outcomes.